Error: Could not add to watchlist. X

Insys Therapeutics Inc

+ Watchlist
INSY:US
NASDAQ GM
44.06
USD
0.34
0.77%
As of 20:10:00 ET on 07/30/2015.
Open
44.63
Day Range
43.00 - 44.65
Volume
468,084
Previous Close
44.40
52Wk Range
11.26 - 44.98
1 Yr Return
192.95%
Open
44.63
Day Range
43.00 - 44.65
Volume
468,084
Previous Close
44.40
52Wk Range
11.26 - 44.98
1 Yr Return
192.95%
YTD Return
109.01%
Current P/E Ratio (TTM)
75.39
Earnings per Share (USD) (TTM)
0.58
Market Cap (b USD)
3.147
Shares Outstanding (m)
71.426
Price/Sales (TTM)
12.24
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Insys Therapeutics, Inc. develops cancer support drugs. The Company's support care candidates include a fast-acting sublingual spray for cancer pain, and a dronabinol product used to treat chemotherapy-induced nausea and vomiting and to stimulate appetite in AIDS patients.
ADDRESS
444 South Ellis Street
Chandler, AZ 85224
United States
PHONE
1-602-910-2617
  • John N Kapoor
    Chairman
  • Michael L Babich
    President/CEO
  • Darryl S Baker
    Chief Financial Officer
  • Amy Raskopf
    Investor Relations
  • Franc E Del Fosse
    Secretary/General Counsel
Show More